7 March 2016 - Under the terms of the arrangement, Specialized Therapeutics grants Mundipharma exclusive marketing, promotion, distribution and sales rights for the anti-nausea and vomiting pharmaceutical products Aloxi and Akynzeo in Australia and New Zealand markets.

For more details, go to: https://www.mundipharma.com.au/specialized-therapeutics-grants-sublicense-for-anti-emetic-products-to-mundipharma-for-australia-and-new-zealand/